Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Haematopoietic stem cells modified with a lentiviral vector containing the CD18 gene

EU orphan designation number: EU/3/16/1753   
Active ingredient: Haematopoietic stem cells modified with a lentiviral vector containing the CD18 gene
Indication: Treatment of leukocyte adhesion deficiency type I
Sponsor: Consorcio Centro de Investigación Biomédica en Red M.P.
Instituto de Salud Carlos III, C/ Monforte de Lemos 3-5, Pabellón 11 Planta 0, (28029) Madrid, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/154/16 (2016)6744 of 14/10/2016
9/10/2017 Change of name and/or address of sponsor